Stock News

Alexion Pharmaceuticals (ALXN) Holder Opus Point Partners Management Decreased Its Position; Alta Capital Management Has Boosted Stake in Starbucks (SBUX) by $468,732 as Valuation Rose

Opus Point Partners Management Llc decreased its stake in Alexion Pharmaceuticals Inc (ALXN) by 67.29% based on its latest 2017Q3 regulatory filing with the SEC. Opus Point Partners Management Llc sold 23,553 shares as the company’s stock declined 11.63% while stock markets rallied. The institutional investor held 11,447 shares of the health care company at the end of 2017Q3, valued at $1.61M, down from 35,000 at the end of the previous reported quarter. Opus Point Partners Management Llc who had been investing in Alexion Pharmaceuticals Inc for a number of months, seems to be less bullish one the $27.42B market cap company. The stock increased 0.19% or $0.23 during the last trading session, reaching $122.71. About 1.23M shares traded. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has declined 18.12% since January 14, 2017 and is downtrending. It has underperformed by 34.82% the S&P500.

Alta Capital Management Llc increased its stake in Starbucks (SBUX) by 1.51% based on its latest 2017Q3 regulatory filing with the SEC. Alta Capital Management Llc bought 8,844 shares as the company’s stock rose 6.99% with the market. The institutional investor held 594,442 shares of the restaurants company at the end of 2017Q3, valued at $31.93 million, up from 585,598 at the end of the previous reported quarter. Alta Capital Management Llc who had been investing in Starbucks for a number of months, seems to be bullish on the $85.94 billion market cap company. The stock increased 0.67% or $0.4 during the last trading session, reaching $60.4. About 6.99 million shares traded. Starbucks Corporation (NASDAQ:SBUX) has risen 12.48% since January 14, 2017 and is uptrending. It has underperformed by 4.22% the S&P500.

Investors sentiment decreased to 0.97 in 2017 Q3. Its down 0.24, from 1.21 in 2017Q2. It dropped, as 95 investors sold SBUX shares while 448 reduced holdings. 100 funds opened positions while 428 raised stakes. 972.68 million shares or 1.58% less from 988.30 million shares in 2017Q2 were reported. Moreover, Keybank National Association Oh has 0.34% invested in Starbucks Corporation (NASDAQ:SBUX). Genesee Valley Trust accumulated 36,406 shares or 0.8% of the stock. Viking Fund Management Ltd Liability Com reported 20,000 shares. Centre Asset Ltd Liability invested 1.17% in Starbucks Corporation (NASDAQ:SBUX). Price T Rowe Assocs Md reported 7.56 million shares stake. Wells Fargo & Mn accumulated 9.03M shares. Denver Invest Advsr Limited Company, Colorado-based fund reported 18,745 shares. 356,165 were reported by Kbc Gru Nv. Moreover, Norinchukin State Bank The has 0.7% invested in Starbucks Corporation (NASDAQ:SBUX). Greenbrier Partners Mngmt Ltd Limited Liability Company invested 2.71% of its portfolio in Starbucks Corporation (NASDAQ:SBUX). Kayne Anderson Rudnick Management Ltd Llc, California-based fund reported 328,233 shares. 126,822 are owned by Salem Inv Counselors. Pggm has invested 0.06% in Starbucks Corporation (NASDAQ:SBUX). 1.85 million were reported by Axa. Moreover, Bright Rock Cap Mgmt Limited Liability Co has 1.5% invested in Starbucks Corporation (NASDAQ:SBUX) for 96,000 shares.

Alta Capital Management Llc, which manages about $1.48B and $1.55B US Long portfolio, decreased its stake in Sherwin Williams Co (NYSE:SHW) by 2,016 shares to 157,221 shares, valued at $56.29M in 2017Q3, according to the filing. It also reduced its holding in Celgene Corp (NASDAQ:CELG) by 14,261 shares in the quarter, leaving it with 354,545 shares, and cut its stake in Novo (NYSE:NVO).

Among 36 analysts covering Starbucks Corporation (NASDAQ:SBUX), 26 have Buy rating, 0 Sell and 10 Hold. Therefore 72% are positive. Starbucks Corporation had 84 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Starbucks Corporation (NASDAQ:SBUX) earned “Hold” rating by Wedbush on Friday, July 28. Argus Research downgraded the stock to “Hold” rating in Friday, February 10 report. The stock of Starbucks Corporation (NASDAQ:SBUX) has “Buy” rating given on Wednesday, September 28 by CLSA. The rating was maintained by Mizuho on Wednesday, November 1 with “Buy”. The rating was maintained by BMO Capital Markets with “Hold” on Tuesday, October 3. The firm has “Buy” rating given on Tuesday, June 13 by BMO Capital Markets. The company was downgraded on Thursday, September 3 by Zacks. On Friday, October 30 the stock rating was maintained by BMO Capital Markets with “Outperform”. The firm has “Market Perform” rating given on Friday, November 3 by BMO Capital Markets. The firm has “Buy” rating given on Monday, May 15 by Deutsche Bank.

Since September 7, 2017, it had 0 buys, and 2 selling transactions for $4.70 million activity. The insider ULLMAN MYRON E III sold 22,966 shares worth $1.23M.

Investors sentiment decreased to 1.17 in 2017 Q3. Its down 0.20, from 1.37 in 2017Q2. It dropped, as 36 investors sold ALXN shares while 174 reduced holdings. 78 funds opened positions while 167 raised stakes. 206.89 million shares or 0.54% less from 208.01 million shares in 2017Q2 were reported. Price T Rowe Assocs Incorporated Md accumulated 22.28 million shares. D Scott Neal owns 1,200 shares for 0.1% of their portfolio. Thrivent For Lutherans accumulated 808,232 shares. Tcw Inc reported 708,121 shares. State Of Tennessee Treasury Department, Tennessee-based fund reported 351,003 shares. Natixis holds 0.1% or 74,267 shares in its portfolio. Advantus Capital invested 0.08% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Zurcher Kantonalbank (Zurich Cantonalbank) reported 0.06% stake. Cadian Cap Limited Partnership holds 1.61% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 245,000 shares. Guggenheim Cap Ltd Liability Corporation owns 0.15% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 447,804 shares. Moreover, Covington Cap Management has 0% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 361 shares. Norinchukin Bancshares The invested 0.05% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Moreover, Kentucky Retirement has 0.15% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Michigan-based Comerica Bancorporation has invested 0.05% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). London Of Virginia has invested 0.61% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN).

Since July 31, 2017, it had 0 buys, and 6 sales for $2.74 million activity. HANTSON LUDWIG sold 2,553 shares worth $310,521. $636,285 worth of stock was sold by O’Neill Julie on Thursday, August 31. 120 shares valued at $16,800 were sold by Wagner Heidi L on Monday, October 2.

Opus Point Partners Management Llc, which manages about $111.46M US Long portfolio, upped its stake in Seattle Genetics Inc (NASDAQ:SGEN) by 6,170 shares to 41,263 shares, valued at $2.25M in 2017Q3, according to the filing.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *